Menu Back to Poster-Presentations-Details
W 48: Regulatory Turnaround Makes India an Increasingly Attractive Location for Clinical Research
- Vice President, Global Operations
Suneela Milind Thatte
Various successful advocacy approaches have been implemented in India, resulting in improved clinical trial regulations due to broader stakeholder involvement, engagement with professional and industry associations, discussions on operational challenges and policy matters, and media education.